
Global Epigenetics Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Epigenetics market size will reach US$ 37190 million by 2031.
Based on product, the global market for epigenetics, is segmented into enzymes, instruments and consumables, kits, reagents, and bioinformatics tools. In 2017, the kits segment accounted for the largest share of global market for epigenetics. The large share of this segment is attributed to the fact that a large number of kits are used in epigenetic techniques. The rising prevalence of a number of diseases, increasing R&D spending, and increased government funding for life science research are the Others factors supporting market growth.
Market growth can be attributed to the decreasing sequencing costs, increase in research activities, availability of funding for epigenetics research, and rising prevalence of cancer.
LPI (LP Information)' newest research report, the “Epigenetics Industry Forecast” looks at past sales and reviews total world Epigenetics sales in 2024, providing a comprehensive analysis by region and market sector of projected Epigenetics sales for 2025 through 2031. With Epigenetics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Epigenetics industry.
This Insight Report provides a comprehensive analysis of the global Epigenetics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Epigenetics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Epigenetics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Epigenetics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Epigenetics.
This report presents a comprehensive overview, market shares, and growth opportunities of Epigenetics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Enzymes
Kits & Assays
Instruments and Consumables
Reagents
Segmentation by Application:
Academic & Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Contract Research Organizations (CROs)
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Merck & Co.
Zymo Research
Abcam
Qiagen
Illumina
Active Motif
Bio-Rad
New England Biolabs
Agilent
Perkinelmer
Diagenode
Epizyme Inc.
CellCentric Ltd.
ValiRx plc
EpiGentek
Please note: The report will take approximately 2 business days to prepare and deliver.
Based on product, the global market for epigenetics, is segmented into enzymes, instruments and consumables, kits, reagents, and bioinformatics tools. In 2017, the kits segment accounted for the largest share of global market for epigenetics. The large share of this segment is attributed to the fact that a large number of kits are used in epigenetic techniques. The rising prevalence of a number of diseases, increasing R&D spending, and increased government funding for life science research are the Others factors supporting market growth.
Market growth can be attributed to the decreasing sequencing costs, increase in research activities, availability of funding for epigenetics research, and rising prevalence of cancer.
LPI (LP Information)' newest research report, the “Epigenetics Industry Forecast” looks at past sales and reviews total world Epigenetics sales in 2024, providing a comprehensive analysis by region and market sector of projected Epigenetics sales for 2025 through 2031. With Epigenetics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Epigenetics industry.
This Insight Report provides a comprehensive analysis of the global Epigenetics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Epigenetics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Epigenetics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Epigenetics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Epigenetics.
This report presents a comprehensive overview, market shares, and growth opportunities of Epigenetics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Enzymes
Kits & Assays
Instruments and Consumables
Reagents
Segmentation by Application:
Academic & Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Contract Research Organizations (CROs)
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Merck & Co.
Zymo Research
Abcam
Qiagen
Illumina
Active Motif
Bio-Rad
New England Biolabs
Agilent
Perkinelmer
Diagenode
Epizyme Inc.
CellCentric Ltd.
ValiRx plc
EpiGentek
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
138 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Epigenetics Market Size by Player
- 4 Epigenetics by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Epigenetics Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.